The relocation of VSY Biotechnology's headquarters from the Netherlands to Germany was announced. The business's new headquarters will be located at VSY Biotechnology GmbH.
Operation of VSY Biotechnology began in the late 1990s. Since then, the company has made significant strides toward becoming a major participant in the market for medical devices that are driven by innovation.
Dr. Fatih Ergin, general manager of VSY Biotechnology, highlights the business' love of innovation and commitment to raising standards everywhere these traits have enabled VSY Biotechnology to garner several innovation awards, international patents, and millions of happy patients together with thousands of satisfied healthcare practitioners.
Dr. Ergin also emphasizes the company's performance throughout the COVID19 crisis, highlighting how VSY Biotechnology did not forego its R&D initiatives or efforts to increase operational efficiency.
“Now is time for us to harvest the outputs of our hard work and dedication as we launch our new pipeline of products and establish our new operational center in Germany,” states Dr. Ergin.